Why Myriad Genetics (MYGN) Stock Is Down Today
Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Joi
Categories:
Myriad Genetics' stock plummets by nearly 20% following Q3 earnings report, as investors react to a lowered full-year earnings forecast, pushing shares down over 50% since January.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
